Archive: 2024 / 03
22
Mar
Trimethoprim-Sulfamethoxazole in AIDS: Analyzing Pharmacokinetics Amid Disease Severity
A critical study reveals the impact of disease severity and ritonavir on the pharmacokinetics of trimethoprim-sulfamethoxazole among HIV/AIDS patients. It suggests tailored dosages are essential for preventing therapeutic failure, highlighting the interaction between disease status and medication.
Read More
0
Comments
